aspirin has been researched along with succinic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duffy, EM; Jorgensen, WL | 1 |
| Lee, CP; Martens, ME | 1 |
| Kolbasov, SE; Kovalenko, AL; Lychakov, AV; Savateeva, TN; Shevchuk, MK | 1 |
| BRUSCH, CA; DORGAN, JA; GRASSE, LA; KEENAN, GF; SARGENT, AF | 1 |
| GILPIN, WA | 1 |
| CONNAMACHER, HS; TILLIS, HH | 1 |
| CRAIN, DC | 1 |
| Brewster, LP; Brey, EM; Burgess, WH; Calceterra, J; Gassman, A; Greisler, HP; Hall, CL; Subramanian, A; Velander, WH; Washington, C; Wolf, W | 1 |
| Bryushinina, OS; Gurto, RV; Slepichev, VA; Stykon, GA; Udut, VV; Yanovskaya, EA; Zyuz'kova, YG | 1 |
| Bokemeyer, C; Hansen, A; Langer, F; Spath, B | 1 |
| Anisimov, VN; Bazhanova, ED; Sukhanov, DS; Teplyĭ, DL | 1 |
11 other study(ies) available for aspirin and succinic acid
| Article | Year |
|---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Reye's syndrome: salicylates and mitochondrial functions.
Topics: Animals; Aspirin; Calcium; Humans; Hydroxybutyrates; Mitochondria; Mitochondria, Liver; NAD; Oxidation-Reduction; Oxygen Consumption; Phosphates; Rats; Reye Syndrome; Salicylates; Salicylic Acid; Structure-Activity Relationship; Succinates; Succinic Acid | 1984 |
Experimental study of biological activity of angiogen in experimental cardiovascular and hemostasis pathology.
Topics: Animals; Aspirin; Blood Coagulation; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Cholesterol; Drug Combinations; Hemostasis; Lipids; Male; Platelet Aggregation Inhibitors; Rats; Succinic Acid | 2002 |
Succinate-salicylate in treatment of arthritic disorders.
Topics: Arthritis; Aspirin; Humans; Salicylates; Succinates; Succinic Acid | 1954 |
Treatment of rheumatoid arthritis and osteoarthritis with succinate-salicylate.
Topics: Arthritis; Arthritis, Rheumatoid; Aspirin; Humans; Osteoarthritis; Salicylates; Succinates; Succinic Acid | 1955 |
Calcium succinate with aspirin in the treatment of rheumatic disease. I. A clinical evaluation.
Topics: Aspirin; Calcium; Humans; Osteoarthritis; Rheumatic Diseases; Succinates; Succinic Acid | 1951 |
Calcium succinate with aspirin as an anti-rheumatic agent.
Topics: Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Aspirin; Calcium; Humans; Osteoarthritis; Succinic Acid | 1951 |
Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen.
Topics: Aspirin; Binding Sites; Cells, Cultured; Chemotaxis; Collagen; Drug Combinations; Enzyme Activation; Fibrin; Fibroblast Growth Factors; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitosis; Protein Binding; Sensitivity and Specificity; Succinic Acid; Thrombin | 2008 |
Pharmacological correction of the negative effects of acetylsalicylic acid on the energy production system.
Topics: Animals; Area Under Curve; Aspirin; Cell Respiration; Energy Metabolism; Heart; Mitochondria; Polarography; Rabbits; Rats; Succinic Acid | 2011 |
Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists.
Topics: Aspirin; Blood Platelets; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Agonists; Receptors, G-Protein-Coupled; Receptors, Purinergic P2Y12; Succinic Acid | 2012 |
[Comparative experimental study of the influence of drugs that improve brain metabolism (angiogen, cytoflavin) on neuronal apoptosis and function of cerebral cortex during aging].
Topics: Aging; Animals; Apoptosis; Aspirin; Behavior, Animal; Caspase 3; Caspase 8; Cerebral Cortex; Cognition; Drug Combinations; Flavin Mononucleotide; Gene Expression; Inosine Diphosphate; Mice; Mice, Transgenic; Motor Activity; Motor Neurons; Neuroprotective Agents; Niacinamide; Sensory Receptor Cells; Succinates; Succinic Acid; Tumor Suppressor Protein p53 | 2015 |